Asl strategic value fund issues open letter to avadel shareholders

Greenwich, conn. & chesterfield, mo.--(business wire)--asl strategic value fund, lp (together with its affiliates, “asl strategic value fund” or “we”), a significant shareholder of avadel pharmaceuticals plc (nasdaq: avdl) (“avadel” or the “company”), today issued an open letter calling on avadel's shareholders to vote against all of the company's director nominees up for election at the 2025 annual general meeting of shareholders scheduled for july 29, 2025 (the “annual meeting”). the full tex.
AVDL Ratings Summary
AVDL Quant Ranking